Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.
Open | $142.800 |
Close | $142.170 |
Volume / Avg. | 299.396K / 381.265K |
Day Range | 140.720 - 144.250 |
52 Wk Range | 66.030 - 161.000 |
Market Cap | $8.049B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 8.52% |
Days to Cover | 11.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ascendis Pharma (NASDAQ: ASND) through any online brokerage.
Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Ascendis Pharma (NASDAQ: ASND) was reported by JP Morgan on Tuesday, April 2, 2024. The analyst firm set a price target for 167.00 expecting ASND to rise to within 12 months (a possible 17.47% upside). 33 analyst firms have reported ratings in the last year.
The stock price for Ascendis Pharma (NASDAQ: ASND) is $142.17 last updated Today at April 17, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Ascendis Pharma.
Ascendis Pharma’s Q1 earnings are confirmed for Monday, April 29, 2024.
There is no upcoming split for Ascendis Pharma.
Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.